TY  - JOUR
AU  - Pericàs, J M
AU  - Moreno, A
AU  - Almela, M
AU  - García-de-la-Mària, C
AU  - Marco, F
AU  - Muñoz, P
AU  - Peña, C
AU  - de Alarcón, A
AU  - Del Río, A
AU  - Eworo, A
AU  - Cruceta, A
AU  - Paré, J C
AU  - Mestres, C A
AU  - Miró, J M
AU  - FOSIMI Investigators
PY  - 2018
DO  - 10.1016/j.cmi.2018.01.010
UR  - http://hdl.handle.net/10668/12088
T2  - Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases
LA  - en
KW  - Aged
KW  - Aged, 80 and over
KW  - Anti-Bacterial Agents
KW  - Bacteremia
KW  - Endocarditis
KW  - Female
KW  - Fosfomycin
KW  - Humans
KW  - Imipenem
KW  - Male
KW  - Methicillin-Resistant Staphylococcus aureus
KW  - Microbial Sensitivity Tests
KW  - Middle Aged
KW  - Treatment Outcome
KW  - Vancomycin
TI  - Efficacy and safety of fosfomycin plus imipenem versus vancomycin for complicated bacteraemia and endocarditis due to methicillin-resistant Staphylococcus aureus: a randomized clinical trial.
TY  - research article
VL  - 24
ER  -